GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Briacell Therapeutics BCT.TO · CAD

Health Care · Toronto Stock Exchange · 🇨🇦 Canada

Compare

5.20

-6.64%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Briacell Therapeutics — daily TSX:BCT Delayed
Market value
C$2.5m
Last close × shares
Volume
5.1k
Shares, 9 Nov 2026

About Briacell Therapeutics

Its shares trade on Toronto Stock Exchange under the ticker BCT.TO. It has been listed since 12 October 2006.

BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company, which engages in the development of immunotherapies for treatment of cancer. The company is headquartered in West Vancouver, British Columbia. The company went IPO on 2006-10-12. The Company’s lead drug candidate, Bria-IMT, is a cell-based patented immunotherapy that stimulates a patient’s own cancer fighting cells to attack and destroy breast cancer tumors. The firm is advancing its targeted immunotherapy program by prioritizing a Phase II clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor. The firm is focused on conducting a Phase I/IIa clinical trial of Bria-IMT in a combination study with Incyte’s immune PD-1 inhibitor, retifanlimab, in advanced breast cancer. The firm is also developing Bria-OTS, an off-the-shelf personalized approach to whole cell cancer immunotherapy. The Bria-OTS immunotherapy is based on a patient’s HLA-type. Its pipeline also includes Bria-Pros, Bria-Lung, Bria-Mel and sCD80, which are in development to treat various cancers.

Figures and description from our data supplier, not checked against the company's own report.

More about Briacell Therapeutics →

Latest on Briacell Therapeutics

Our reporting

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Briacell Therapeutics's ticker?

Briacell Therapeutics trades as BCT.TO on Toronto Stock Exchange, under ISIN CA1079303071.

What was Briacell Therapeutics's last closing price?

5.20 on 9 Nov 2026. The figure is in CAD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.